Bradenton, FL (PRWEB) August 28, 2014
Cactus Sky Digital, industry leader in email marketing announces its collaboration with online marketing and lead generator giant, AutoeDealers, to dramatically increase the amount of closed sales for their clients with CRMGold.
The partnership is due to recent studies revealing a high percentage of consumers preferred to research products and services online prior to purchase. According to a report by Cisco, 83 percent of consumers prefer to research online for vehicle information.
CRMGold encompasses lead reactivation, database cleaning and mobile-centric multi-channel marketing available with a flexible pricing model affordable to dealerships of all sizes. CRMGold maximizes engagement with dormant prospects utilizing a multi-channel approach. Through CRMGold, dealers get custom creative content catered to the recipient.
CRMs are not designed to provide mobile enabled emails although many dealers often believe they are. To optimally target prospective leads, mobile enabled emails are more important than ever. 65% of all emails get opened first on a mobile device. 78% of emails that do not adapt to the mobile screen will be deleted. CRMGold tackles this challenge and leverages other mobile marketing channels integral to the modern marketing campaign.
"Lead generation is vital and with AutoeDealers we can increase the quality and quantity of leads that we offer dealerships on our CRMGold," explained Peter "the Webdoc" Martin, President of Cactus Sky Digital.
CRMGold sends automated messages to desolate prospects in a dealership's customer relationship management system (CRM). These messages are targeted to each prospect and are proven to initiate a sale. CRMGold is built off of the Pot of Gold Program, a leader in dealership closing ratios and is known for generating dealership traffic.
"Cactus Sky has years of online marketing experience with the automotive industry. A partnership with AutoeDealers only made sense. AutoeDealers helps us better capture leads for our CRMGold clients and helps them make more sales, which is ultimately our number one priority," said Martin.
About Cactus Sky Digital
Cactus Sky is a full-service online advertising and public relations agency whose services increase and expand leads, sales and revenue. The company offers: website design, email marketing, online contests, database management, social media, public relations, online advertising, search engine marketing and mobile messaging. Cactus Sky has the largest consumer and business opt-in email database in the industry. To learn more about Cactus Sky Digital and its marketing solutions visit: http://www.cactusskydigital.com.
AutoeDealers is an eMarketing company offering a strategic suite of proven lead generation and marketing solutions. Using "Automated eSolutions to Turn Clicks into Clients", AutoeDealers helps dealers maximize the quantity and quality of their lead generation and marketing efforts by driving in-market shoppers to your website and offering engagement tools to the customer and encourages them to take action, resulting in more qualified leads and clients from your company's website. Mike Shawd, President of AutoeDealers, has over 26 years automotive industry experience in both retail and on the vendor side with AutoUSA and DigiGo. For more information about AutoeDealers visit: http://www.autoedealers.com.
Read the full story at http://www.prweb.com/releases/2014/08/prweb12130846.htm
Midland, TX (PRWEB) August 28, 2014
The Federal Aviation Administration (FAA) proposed a new policy on July 22, 2014, to address the non-aeronautical use of airport hangars. A summary of the proposed Non-aeronautical Use of Airport Hangars rule stated on the regulations.gov website reads, "Under Federal law, airport operators that have accepted federal grants and/or those that have obligations contained in property deeds for property transferred under various Federal laws such as the Surplus Property Act generally may use airport property only for aviation-related purposes unless otherwise approved by the FAA. Compliance inspections by FAA staff, as well as audits by the Government Accountability Office, have found that some hangars intended for aircraft storage are routinely used to store non-aeronautical items such as vehicles and large household items. In some cases, this storage interferes with--or entirely displaces--aeronautical use of the hangar. Moreover, many airports have a waiting list for hangar space, and a tenant's use of a hangar for non-aeronautical purposes prevents aircraft owners from obtaining access to hangar storage on the airport. At the same time, the FAA realizes that storage of some small incidental items in a hangar that is otherwise used for aircraft storage will have no effect on the aeronautical utility of the hangar. The FAA is proposing a statement of policy on use of airport hangars to clarify compliance requirements for airport sponsors, airport manager, airport tenants, state aviation officials, and FAA compliance staff. This notice solicits public comment on the proposed policy statement."
According to Stephan Brown, president and CEO of the Commemorative Air Force, "the CAF and many other non-profit aviation museums around the country exhibit static and flying aircraft in hangars for the purpose of education. However, many non-aeronautical items are also displayed in order to tell these stories. Additionally, food service, merchandise and other revenue-producing operations occur that are supplementary to education and crucial to the business operations of aviation museums. In addition, the CAF's 60 unit locations, along with hundreds of other aviation museums, experimental, limited and standard category aircraft undergo multi-year restoration efforts - this new rule would threaten those efforts. The CAF is requesting an extension of the comment period on the proposed rule for non-aeronautical uses of aircraft hangars in order for more comments to be registered and for the FAA to delve deeper into the unintended consequences of this proposed rule."
The Commemorative Air Force will continue to coordinate with the responsible government agencies as well as track this situation because of the potential direct impact to the organization's operations. To bolster the organization's efforts, the CAF has made requests to its membership and supporters to voice their concerns about the potential impact of this proposed rule via public comment. Those wanting to voice their opinions must do so before September 5, when the public comment period ends.
The CAF's official statement requests the policy clearly establish aviation museums/static aircraft displays, aircraft building/restoration, non aviation historical/educational supporting artifacts, signs and other museum support functions such as food and beverage operations, as an approved aeronautical purpose. The statement goes on to say "all of our hangars are used for storing, restoring and performing maintenance on our flying aircraft, as well as museum educational operations. Within some of the larger hangars, they maintain artifacts associated with the history of the airplanes, the wars and battles associated with the era and use them to tell the story about the role of the aircraft and the men and women who flew them to preserve our peace and that of our allies. In some cases we maintain multiple hangars and buildings as a campus, some of which are for the interpretive displays and viewing of artifacts by the public. In all cases, the focus is on our educational mission, as a flying museum and we display the static elements as supporting and necessary elements of the total story and history."
Aviation enthusiasts and members of various aviation organizations have posted over 700 comments. Several comments expressed concern regarding restrictions affecting the early stages of the homebuilt aircraft projects. "With the comments mounting and actions being taken directly with government agencies, the best outcome would be an industry meeting with the FAA to be sure they understand the concerns and possible impact on aviation non-profit organizations and museums," concluded Brown.
Comments may be placed by visiting the following link: http://www.regulations.gov/#!documentDetail;D=FAA-2014-0463-0001
In 1957, a small group of ex-service pilots pooled their money to purchase a P-51 Mustang, beginning what is now called the Commemorative Air Force (CAF). With the addition of a pair of F8F Bearcats, the CAF became the founders of the Warbird Movement, an effort to preserve and honor our military history with the rallying cry to "Keep 'Em Flying!" Nearly 60 years later, the CAF is the premier Warbird organization, with a fleet of 162 vintage aircraft. A non-profit educational association, the CAF has more than 12,000 members and its fleet of historic aircraft is distributed to more than 80 units located in 26 states. For more information, visit http://www.commemorativeairforce.org or call (432) 563-1000.
Read the full story at http://www.prweb.com/releases/2014/08/prweb12130739.htm
(PRWEB) August 28, 2014
Some life insurance plans like whole life insurance build cash value in a savings account. Having life coverage is important for providing financial stability for vulnerable family members.
A life insurance policy requires medical examinations to qualify for coverage. However, some plans can be purchased online. No medical exam life insurance policies do not feature a savings account and clients cannot use them to save money for college expenses.
Whole life insurance is the only policy that can help clients save money for college costs. A policy will build cash value and the accumulated savings can be used by the insured to cover financial expenses.
Lifeinsure.biz is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.
Lifeinsure.biz is owned by Internet Marketing Company.
For more information, please visit http://lifeinsure.biz/ .
BEDFORD, Mass.--(BUSINESS WIRE)-- Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the second quarter ended June 30, 2014.
“The past several months have been transformational for Ocular Therapeutix,” said Amar Sawhney, Ph.D., President and Chief Executive Officer. “With the closing of our IPO in July, our solid balance sheet should enable the Company to progress with its robust clinical development programs in pain and inflammation, glaucoma and ocular hypertension, and chronic allergic conjunctivitis.” Dr. Sawhney continued, “We look forward to advancing our pipeline further in the second half of 2014 with the anticipated initiation of a Phase 2b clinical trial of our OTX-TP product candidate for the treatment of glaucoma and ocular hypertension. We are also continuing to advance our Phase 3 clinical trials of our OTX-DP product candidate for the treatment of post-surgical ocular inflammation and pain.”
Second Quarter 2014 Financial Results
Ocular reported a net loss attributable to common stockholders of approximately $6.4 million, or $2.10 per share, for the quarter ended June 30, 2014, compared to $3.1 million, or $1.19 per share, for the quarter ended June 30, 2013. The second quarter 2014 results include $3.4 million in non-cash charges for stock-based compensation and licensing and consultant fees paid in common stock compared to $0.2 million in such non-cash charges in the second quarter of 2013.
Total operating expenses for the quarter ended June 30, 2014 were $6.0 million as compared to $3.0 million for the quarter ended June 30, 2013. Research and development (R&D) expenses for the quarter ended June 30, 2014 were $4.3 million, compared to $2.4 million for the second quarter of 2013. This increase is primarily related to the clinical development of the Company’s product pipeline, including the Phase 3 clinical trials of its OTX-DP product candidate for the treatment of post-surgical ocular inflammation and pain, the Phase 2 clinical trials of its OTX-DP product candidate for the treatment of chronic allergic conjunctivitis and a Phase 2a clinical trial of its OTX-TP product candidate for the treatment of glaucoma and ocular hypertension.
Ocular generated $0.1 million of revenue during the three months ended June 30, 2014 from initial sales of ReSure® Sealant. Sales of ReSure® Sealant commenced in the first quarter of 2014 and limited sales are anticipated during 2014 as the company seeks to build awareness of this product through a network of independent medical device distributors across the United States.
As of June 30, 2014, cash, cash equivalents, and short-term investments totaled $19.9 million. Subsequent to the end of the second quarter, Ocular completed an initial public offering (IPO) of its common stock and received $66.5 million in net proceeds.
Summary of Year-to-Date 2014 Accomplishments
- Ocular received net proceeds of approximately $66.5 million from the issuance and sale of 5,750,000 shares of its common stock in its IPO, including shares issued upon the exercise in full of the underwriters' over-allotment option.
- On July 25, 2014, Ocular’s shares began trading on the NASDAQ Global Market under the symbol "OCUL".
- Ocular strengthened its leadership team with the appointment of Bruce Peacock, a seasoned executive with significant experience in the biopharmaceutical industry, to the Board of Directors, and with the appointment of Brad Smith, an executive with experience with both public and private life sciences companies, as Chief Financial Officer.
- The American Medical Association (AMA) CPT Editorial Panel granted Ocular a Category III CPT code 0356T for the insertion of a drug-eluting implant in the punctum, a natural opening in the eyelid near the tear ducts. The new Category III CPT code, designated for emerging technologies, services, and procedures, became effective July 1, 2014.
- In January 2014, Ocular received approval from the U.S. Food and Drug Administration (FDA) to commercialize the ReSure® Sealant in the United States, indicated for prevention of postoperative fluid egress from corneal incisions with a demonstrated wound leak following cataract surgery. The ReSure® Sealant is the first and only surgical sealant that is FDA-approved for ophthalmic use.
Recent Clinical Highlights
- Ocular completed a 41-patient Phase 2a clinical trial of OTX-TP for the treatment of glaucoma and ocular hypertension. One of the two OTX-TP dosing arms of the study appeared to show reduction of intraocular pressure similar to comparator Timolol eye drops, although the trial was not powered to measure any endpoints with statistical significance. The results of this clinical trial provided valuable information for the design of a Phase 2b clinical trial of this product.
- In March, Ocular initiated a Phase 3 clinical program to evaluate the safety and efficacy of its OTX-DP product candidate, which incorporates the FDA approved corticosteroid dexamethasone as an active pharmaceutical ingredient, for the treatment of post-operative ocular inflammation and pain. Ocular has designed OTX-DP to provide a sustained, tapered release of dexamethasone over a period of approximately 30 days.
- Ocular presented six posters at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Orlando, Florida, from May 4-8, 2014.
- Ocular presented eleven podium and posters, including clinical data on its ReSure® Sealant and sustained release dexamethasone, at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium in Boston, Massachusetts, from April 25-29, 2014.
Anticipated Clinical Milestones and Development Plans
- During the fourth quarter of 2014, Ocular intends to initiate a Phase 2b clinical trial of OTX-TP for the treatment of glaucoma and ocular hypertension.
- During the fourth quarter of 2014, Ocular expects to release Phase 2 clinical trial data of OTX-DP for the treatment of chronic allergic conjunctivitis. A total of 60 patients have been randomized 1:1 to receive either OTX-DP or a proprietary placebo punctum plug, using a Modified Conjunctival Allergen Challenge Model (CAC™). OTX-DP is administered as a one-time sustained release corticosteroid with a four-week release. Primary endpoints of the Phase 2 trial include ocular itching and conjunctival redness.
About Ocular Therapeutix
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Ocular Therapeutix’s lead product candidates are in Phase 3 clinical development for post-surgical ocular inflammation and pain, and Phase 2 clinical development for glaucoma, ocular hypertension and chronic allergic conjunctivitis. The Company is also evaluating sustained-release injectable anti-VEGF drug depots for back-of-the-eye diseases. Ocular Therapeutix’s first product, ReSure® Sealant, is FDA-approved to seal corneal incisions following cataract surgery.
“Any statements in this press release about future expectations, plans and prospects for the Company, including statements about the development of the Company’s product candidates, such as the timing and conduct of the Company’s Phase 3 clinical trial of OTX-DP for the treatment of post-operative inflammation and pain following cataract surgery and the Company's Phase 2b clinical trial of OTX-TP for the treatment of glaucoma and ocular hypertension, the expected timing to release data relating to the Company’s Phase 2 clinical trial of OTX-DP for the treatment of chronic allergic conjunctivitis, pre-commercial activities, the advancement of the company's earlier stage pipeline, future sales of ReSure Sealant and other statements containing the words "anticipate," "believe," "estimate," "expect," "intend", "goal," "may", "might," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including statements about the clinical trials of our product candidates. Such forward-looking statements involve substantial risks and uncertainties that could cause Ocular Therapeutix’ clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, those related to the timing and costs involved in commercializing ReSure® Sealant, the initiation and conduct of clinical trials, availability of data from clinical trials and expectations for regulatory approvals, the Company’s scientific approach and general development progress, the availability or commercial potential of the Company’s product candidates, the sufficiency of cash resources and need for additional financing or other actions and other factors discussed in the “Risk Factors” section of the final prospectus for the Company’s IPO, which is on file with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of the date of this release. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this release.”
Statements of Operations and Comprehensive Loss
(In thousands, except share and per share data)
|Three Months EndedJune 30,||Six Months EndedJune 30,|
|Cost of revenue||20||—||29||—|
|Research and development||4,292||2,404||9,250||4,891|
|Selling and marketing||535||143||845||280|
|General and administrative||1,196||442||2,771||878|
|Total operating expenses||6,043||2,989||12,895||6,049|
|Loss from operations||(5,946||)||(2,989||)||(12,771||)||(6,049||)|
|Other income (expense):|
|Other income (expense), net||(190||)||3||(331||)||7|
|Total other income (expense), net||(446||)||(101||)||(629||)||(241||)|
|Net loss and comprehensive loss||(6,392||)||(3,090||)||(13,400||)||(6,290||)|
|Accretion of redeemable convertible preferred stock to redemption value||(5||)||(9||)||(11||)||(17||)|
|Net loss attributable to common stockholders||$||(6,397||)||$||(3,099||)||$||(13,411||)||$||(6,307||)|
|Net loss per share attributable to common stockholders, basic and diluted||$||(2.10||)||$||(1.19||)||$||(4.54||)||$||(2.45||)|
|Weighted average common shares outstanding, basic and diluted||3,044,605||2,595,771||
Ocular Therapeutix, Inc.
(In thousands, except share and per share data)
|Cash and cash equivalents||$||19,944||$||17,505|
|Accounts receivable from related party||1||19|
|Deferred offering costs||2,197||—|
|Prepaid expenses and other current assets||283||240|
|Total current assets||22,594||18,014|
|Property and equipment, net||1,152||904|
|Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Deficit|
|Notes payable, net of discount, current||1,085||1,806|
|Total current liabilities||4,489||3,342|
|Preferred stock warrants||852||254|
|Deferred rent, long-term||119||27|
|Notes payable, net of discount, long-term||13,594||651|
|Commitments and contingencies (Note 11)|
Redeemable convertible preferred stock (Series A, B, C, D and D-1),$0.001 par value; 34,229,025 and 33,979,025 shares authorized atJune 30, 2014 and December 31, 2013, respectively; 32,842,187shares issued and outstanding at June 30, 2014 and December 31,2013; aggregate liquidation preference of $74,436 at June 30, 2014and December 31, 2013
Common stock, $0.0001 par value; 47,500,000 and 45,000,000shares authorized at June 30, 2014 and December 31, 2013,respectively; 3,129,285 and 2,676,648 shares issued and outstanding at June 30, 2014 and December 31, 2013,respectively
|Additional paid-in capital||4,745||1,308|
|Total stockholders’ deficit||(69,435||)||(59,472||)|
|Total liabilities, redeemable convertible preferred stock and stockholders’ deficit||$||23,974||$||19,146|
Ocular Therapeutix, Inc.
Chief Financial Officer
Burns McClellan on behalf of Ocular Therapeutix
Kimberly Minarovich, 212-213-0006
Vice President of Sales and Marketing
Source: Ocular Therapeutix, Inc.
WASHINGTON, Aug. 28, 2014 /PRNewswire-USNewswire/ -- Letter carriers who emptied burning buildings, rescued a boy from a predator, saved a heart attack victim or brightened holidays will be honored Sept. 10.
Connecticut letter carrier Jermaine Shirley, who smelled smoke in an apartment building one morning, alerted residents and caught two young children thrown from a window as fire engulfed the building, is the 2014 National Hero of the Year. Peoria, IL, carriers Cristy Perfetti and Steve Plunkett, Unit Citation recipients, rescued a boy abducted at knifepoint, brought him to safety in their post office and trailed the suspect, who had prior convictions for crimes against children and soon returned to prison. Victor Green, a New York metro area carrier, will posthumously receive the Legacy Award for helping a generation of black Americans travel safely and without shame in pre-civil-rights-era America by publishing an annual travel guide to inns and private homes that accepted African-Americans.
Several other carriers also are being recognized as heroes. They represent thousands of letter carriers who not only deliver the mail to 150 million households and businesses six days a week, but often assist in situations involving accidents, fires, crimes or health crises.
Western Region Hero Steve Filson of Oregon saved the life of a man suffering heart failure. Central Region Hero Jim Rurik of Columbus, OH, smothered the burning clothes of a fire victim with his postal jacket; then evacuated all residents of the building. Eastern Region Hero Robert George of Worcester, MA, an Air Force veteran, pulled a driver to safety before the man's crashed truck burst into flames. Humanitarian of the Year Orlando Gonzales of New York City organized an annual walk of letter carriers to raise money for the Muscular Dystrophy Association. Carriers in Reading, PA, who've provided holiday necessities for a decade, will receive the Branch Service Award.
The NALC Heroes of the Year will be honored by Fredric Rolando, president of the National Association of Letter Carriers, at a special luncheon at noon Sept. 10 in the National Press Club Ballroom, 529 14th St. NW, Washington, DC. Go to http://nalc.org/heroes for further information on the Heroes.
The NALC represents letter carriers across the country. Its 280,000 members make it the largest of the four unions representing employees of the United States Postal Service. Founded by Civil War veterans in 1889, the NALC is among the country's oldest labor unions.
SOURCE National Association of Letter Carriers
More Press ReleasesView Older Stories
No Medical Exam Life Insurance Plans Provide Underwriting for Clients Who Have Health Problems
Stop-painting.com Set to Host Exhibit at 2014 IMTS
Best Life Insurance Rates for 2014 Now Promoted at Insurer Website
Nashville Area MPO Seeks Community Input
Dr. Anthony Geroulis Utilizes DERMAPEN Micro Needling Treatment to Dramatically Improve Stretch Marks
InventHelp® Client's Alternative Bowl Keeps Contents Cool for Longer Periods (FLA-2462)
Life Insurance No Exam Required Can Provide Financial Protection for Families!
Compare Term Life Insurance Quotes Online to Find The Best Rates
California Car Insurance Rates Now Searchable from New Insurer Finder Online
Hopt Soda Wins Platinum A' Design Award
WIOD Radio Personality Keith Singer Interviews Actor Patrick Dempsey on "Making a Difference"
New Iron Workers Membership Card Consolidates Skills and Qualifications
The Carneros Wine Alliance Announces Area Wineries Are Open for Business this Labor Day Weekend, and Eager to Spread #CarnerosLove
InventHelp® Client Develops Dating Aid (FED-1279)
SunShare Announces Program to Provide Free Electricity from its Community Solar Garden to Families of Students At Academy 360
Investing in the Quality of Life in New Center Detroit
Ambassador Cuisia, TRANSFAST CEO Meet to Discuss Further Enhancing International Commerce to the Philippines
Drug Use Causes Problems in the Workplace
Arizona State University Grad Student in the Running for College Entrepreneur of the Year
Poptropica's New Quest, PoptropiCon, Immerses Players in the Wild World of a Fan Convention
Dirty Words and Smart Ass Fill Gift Bags at the MTV Video Music Awards
Joule to Host Strategic Seminar on Climate Change in Norway, Featuring Jeffrey Sachs
Millennium Treatment Group Works to Close Treatment Gap
LA Chinatown Celebrates 76th Annual Moon Festival
Shore & Country Properties Releases Mid Year Numbers
Millennium Treatment Group Celebrates National Recovery Month
Carter’s, Inc. Announces Participation at the Goldman Sachs Global Retailing Conference
New West Energy Services Inc. Announces Its Fourth Quarter and Full Year Results
Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task?
Granting the Wish of a Make-A-Wish® Founder
American Electric Technologies CEO to Present at Euro Pacific Global Investment Conference
American Electric Technologies CEO to Present at Euro Pacific Global Investment Conference
Area Post-Hardcore Band TragedyOfAHero to Release Debut Album in Fall 2014
Fitch Affirms ML-CFC 2006-1
California City First in San Diego County to Develop Comprehensive Sustainability Action Plan for Municipal Operations
Ur-Energy Completes Technical Report on Shirley Basin Uranium Project
WorldVentures Ranks No. 2333 on the 2014 Inc. 5000 List of America's Fastest-growing Private Companies
GetResponse Wins Gold and Bronze Stevie® Awards in 2014 International Business Awards
American IRA-A National Self-Directed IRA Provider-Announces A New 2-Part Blog "Property Management in Real Estate IRAs."
Southern California CPA Firm Remains Top Southern California CPA Firm and Moves Up in National Rankings
Larson Jewelers Expands Wood Inlay Rings Line
Altibase's In-Memory Database Combines Hybrid Architecture and Big Data Adapter to Solve Sensor Data Processing Problems in Single Solution
Diamond and Rolex Trade-Up Deals Return to Sissy's Log Cabin
PineCrest is AppMakr's Mobile App Of The Week for August 24th - 30th
West Melville Closes Second Tranche of Financing
NoBullying Examines Today the Ongoing Ordeal of College Hazing
Working Capital Provided by National Community Fund to Strengthen Mill and Retain 971 Jobs at Roseburg Forest Products
2015 National Financial Plan Competition Registration Begins
Royal Gold Announces Fourth Quarter Dividend
Join SanDiego.com at This Year's Brazilian Day Festival